Present Change: Organogenesis (NASDAQ: ORGO)
Organogenesis is in the healthcare sector and is in the drug manufacturers industry. The company CEO is Gary S. Gillheeney.
Read more
ORGO
Wall Street News24
Taking Your Financial Future To New Heights